Julien Taieb - Université Paris Cité

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 300 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Relationship Between Fluoropyrimidine (FPD) Exposure and Outcomes in Patients with Metastatic Colorectal Cancer (mcrc) Receiving Trifluridine/tipiracil (FTD/TPI) with or Without Bevacizumab (BEV) in the Phase 3 SUNLIGHT Trial

Marwan Fakih,Gerald W. Prager,Julien Taieb, Elizabeth Martine Calleja,Mei Liu,Nadia Amellal,Josep Tabernero

JOURNAL OF CLINICAL ONCOLOGYno. 3_SUPPL (2024): 114-114

引用0浏览0引用

Early-Onset Colorectal Cancer: from the Laboratory to the Clinic

Annalice Gandini,Julien Taieb,Hélène Blons,Jeanne Netter,Pierre Laurent-Puig,Claire Gallois

Cancer Treatment Reviewspp.102821, (2024)

引用0浏览0WOS引用

Impact of KRASG12 Mutations on Survival with Trifluridine/tipiracil Plus Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer: Post Hoc Analysis of the Phase III SUNLIGHT Trial

J. Tabernero,J. Taieb,M. Fakih,G. W. Prager,E. Van Cutsem,F. Ciardiello, R. J. Mayer,N. Amellal,D. Skanji, E. Calleja,T. Yoshino

ESMO OPENno. 3 (2024)

引用0浏览0WOS引用

508Tip PRODIGE 68 - UCGI 38 - SOREGATT: A Randomized Phase II Study Comparing the Sequences of Regorafenib (reg) and Trifluridine/tipiracil (t/t) after Failure of Standard Therapies in Patients (pts) with Metastatic Colorectal Cancer (Mcrc)

M. P. Ducreux,A. Parzy,M. Ben Abdelghani,J. Martin-Babau,D. Tougeron,D. Botsen,J. Taieb,D. Pannier,F. Khemissa, J. Viaud,A. L. Villing,O. Bouche,A. Peytier, H. Alexandre, F. Garic,M-L. Tanguy,J-B. Bachet

Annals of oncology（2024）

引用0浏览0引用

Clinical Impact of Circulating Tumor DNA to Track Minimal Residual Disease in Colorectal Cancer Patients. Hopes and Limitations

C. Soueidy,A. Zaanan,M. Gelli,E. Moati,C. Gallois,V. Taly,P. Laurent-Puig,L. Benhaim,J. Taieb

ESMO Gastrointestinal Oncology (2024): 100068

引用0浏览0引用

66P Targeted treatment (TT) after immune checkpoint inhibitors (ICIs) in BRAF V600E mutated (BRAFm) and deficient mismatch repair or microsatellite instability high (dMMR/MSI-H) metastatic colorectal cancer (mCRC)

M. Ambrosini,D. Tougeron,D.P. Modest,R. Guimbaud,S. Kopetz, M. Decraecker,F. Sclafani,C. Coutzac,A. Lievre, E.L. Alouani,F. Marmorino,S. Pernot,F.A. Sinicrope,M.E. Elez Fernandez,M.M. Germani,F. Pietrantonio,S. Lonardi, P. Parent,C. Gallois,J. Taieb

Annals of Oncology (2024)

引用0浏览0引用

Overcoming Barriers in Biomarker Testing. Letter to the Editor Regarding: “ESMO Study on the Availability and Accessibility of Biomolecular Technologies in Oncology in Europe”, by A. Bayle Et Al

J. García-Foncillas, D. Arnold, B. Avouac,U. Lassen,P. Laurent-Puig,J. Taieb,Å. Helland,A. Stenzinger

Annals of Oncology (2024)

引用0浏览0WOS引用

Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer

Thierry André,Eric Van Cutsem,Julien Taieb,Marwan Fakih,Gerald W. Prager,Fortunato Ciardiello,Alfredo Falcone,Mark Saunders,Nadia Amellal, Lucas Roby,Josep Tabernero,Per Pfeiffer

Current Treatment Options in Oncologypp.1-11, (2024)

引用0浏览0WOS引用

Impact of Colorectal Liver Metastases (CRLM) in Patients with Metastatic Colorectal Cancer (mcrc) Receiving Trifluridine/tipiracil (FTD/TPI) with or Without Bevacizumab (BEV) in the Phase 3 SUNLIGHT Trial

Josep Tabernero, Gerald W. Prager,Julien Taieb, Elizabeth Martine Calleja, Mei Liu,Nadia Amellal,Marwan Fakih

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn